Merck & Co vs UnitedHealth Group
Merck & Co (MRK), health care, and UnitedHealth Group (UNH), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Merck & Co and UnitedHealth Group are valued at about the same: $354.4B and $357.1B. Merck & Co trades at 145 times earnings and UnitedHealth Group at 22.7. Over the past year Merck & Co's share price has moved +49.8% and UnitedHealth Group's +31.4%.
Key facts
- Merck & Co market value
- $354.4B
- UnitedHealth Group market value
- $357.1B
- Merck & Co P/E
- 145
- UnitedHealth Group P/E
- 22.7
- Merck & Co revenue
- $65BFY to 2025-12-31
- UnitedHealth Group revenue
- $447.6BFY to 2025-12-31
- Superinvestors holding both
- 11
Market values as of .
| Measure | Merck & Co | UnitedHealth Group |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $354.4Blower | $357.1Bhigher |
| Revenue | $65Blower | $447.6Bhigher |
| Earnings | $18.3Bhigher | $12.1Blower |
| Employees | 73,000lower | 390,000higher |
| Total assets | $136.9Blower | $309.6Bhigher |
| Valuation | ||
| P/E | 145higher | 22.7lower |
| P/S | 5.5higher | 0.8lower |
| P/B | 7.9higher | 3.6lower |
| Dividend yield | 2.33%higher | 2.20%lower |
| Profitability | ||
| Operating margin | — | 4.24% |
| Balance sheet | ||
| Net assets | $52.6Blower | $100.1Bhigher |
| Total liabilities | $84.2Blower | $207.9Bhigher |
| Total debt | $49.3Blower | $77.7Bhigher |
| Cash on hand | $14.6Blower | $24.4Bhigher |
| Price change | ||
| Today | -0.48%higher | -3.27%lower |
| 1 year | +49.8%higher | +31.4%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (11)
- Bill Smead7.1% / 2.5%
- Ken Fisher1.7% / 1.1%
- Jeremy Grantham (co-founder)1.6% / 2.2%
- Charles Brandes (founder)1.5% / 1.0%
- Sarah Ketterer0.6% / 0.3%
- Cliff Asness0.4% / 0.3%
- Temasek0.3% / 0.5%
- Ken Griffin0.1% / 0.3%
- Mairs & Power team0.1% / 1.7%
- Dodge & Cox team<0.1% / 1.6%
- Rajiv Jain<0.1% / 0.8%
Merck & Co only (12)
- Thomas Kahn4.9%
- Bill Nygren2.1%
- Howard Gleicher2.0%
- Josef Lakonishok1.4%
- Prem Watsa0.9%
- Christopher Bloomstran0.6%
- Mark Boyar0.5%
- David Shaw (founder)0.2%
- Brandon Haley0.2%
- Joel Greenblatt0.2%
- Murray Stahl0.1%
- Thomas Russo<0.1%
UnitedHealth Group only (18)
- Samantha McLemore5.2%
- Sequoia Fund team4.2%
- Christopher Davis2.0%
- Lew Sanders2.0%
- Andrew Spokes2.0%
- Doug Silverman1.4%
- Pat English1.4%
- Jim Simons (1938–2024)1.1%
- Duan Yongping0.9%
- Stephen Yacktman0.8%
- Steve Cohen0.5%
- Paul Tudor Jones0.5%
- Chase Coleman0.5%
- C.T. Fitzpatrick0.5%
- Israel Englander0.5%
- Robert Pitts0.4%
- Tweedy, Browne team0.1%
- Jensen team<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Merck & Co / UnitedHealth Group). Who owns MRK · Who owns UNH
More on Merck & Co
Further comparisons
Merck & Co against its closest peers
UnitedHealth Group against its closest peers
Learn
Questions and answers
Which is bigger, Merck & Co or UnitedHealth Group?
By market value, UnitedHealth Group is the larger: $357.1B against $354.4B for Merck & Co. By revenue in its latest fiscal year, UnitedHealth Group is the larger: $447.6B against $65B for Merck & Co.
Which has the higher P/E ratio?
Merck & Co: 145, against 22.7 for UnitedHealth Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher dividend yield?
Merck & Co: 2.33%, against 2.20% for UnitedHealth Group. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
UnitedHealth Group: $77.7B, against $49.3B for Merck & Co. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Merck & Co and UnitedHealth Group?
In their latest 13F filings, Bill Smead, Ken Fisher, Jeremy Grantham (co-founder), Charles Brandes (founder), Sarah Ketterer, Cliff Asness, Temasek, Ken Griffin, Mairs & Power team, Dodge & Cox team and Rajiv Jain hold both.
Cite this page
Funkfolio, “Merck & Co vs UnitedHealth Group”, data as of 17 November 2026. https://funkfolio.com/compare/mrk-vs-unh
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.